Adjunctive middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis of randomized controlled trials
Adjunctive MMAE reduces the risk of recurrence, hematoma progression, or the need for surgical rescue compared to standard care, without increasing all-cause mortality or stroke, while achieving comparable functional outcomes (mRS 0-2) at 90 days.
Authors
- Farhan Siddiq (ORCID: https://orcid.org/0000-0001-8568-1543)
- Yilun Huang (ORCID: https://orcid.org/0009-0002-0267-1716)
- Muhammad Shakir (ORCID: https://orcid.org/0000-0002-7233-1584)
- Zuhaib Ali
Institutions
- Aga Khan University (TZ)
- University of Missouri (US)
Publication Details
- Journal
- Neurological Research
- Published
- 2025-11-23
- DOI
- https://doi.org/10.1080/01616412.2025.2592857
- Primary Topic
- Neurosurgical Procedures and Complications
- Type
- article
- Field-Weighted Citation Impact
- 0.00